Phosphorylated α-Synuclein in Parkinson’s DiseaseYu Wang, Jing Zhang, Kathryn A. Chung et al.|Science Translational Medicine|2012Cited by 277
Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humansMaria L. Maccecchini, Nigel H. Greig, Mee Young Chang et al.|Journal of Neurology Neurosurgery & Psychiatry|2012Cited by 90
Phosphorylated alpha-Synuclein in Parkinson's DiseaseYu Wang, Jing Zhang, Min Shi et al.|Science Translational Medicine|2012Cited by 77